| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.184.138.486 $ | +353.349.787 $ | +35,7 % | 7 | 1.151.920.009 $ | +465.108.015 $ | +75,7 % | 9 | 798.479.540 $ | +254.993.478 $ | +60,6 % | 9 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 211.826.559 $ | -107.974.848 $ | -33,8 % | 1 | 319.801.407 $ | +190.512.325 $ | +147,4 % | 1 | 129.289.082 $ | +84.588.980 $ | +189,2 % | 1 |
| Damora Therapeutics, Inc. | GLTO | → 0 | 225.666.700 $ | +225.666.700 $ | 1 | ||||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 212.921.069 $ | +124.847.428 $ | +141,8 % | 1 | 88.073.641 $ | -42.064.325 $ | -32,3 % | 1 | 130.137.966 $ | +79.702.998 $ | +158,0 % | 1 |
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 202.673.014 $ | +71.040.025 $ | +54,0 % | 1 | 131.632.989 $ | +64.289.616 $ | +95,5 % | 1 | ||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 181.743.101 $ | +69.436.610 $ | +61,8 % | 1 | 112.306.491 $ | +41.054.303 $ | +57,6 % | 1 | 71.252.188 $ | +33.452.942 $ | +88,5 % | 1 |
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 154.631.876 $ | +73.239.131 $ | +90,0 % | 1 | 81.392.745 $ | -7.579.994 $ | -8,5 % | 1 | ||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 76.566.798 $ | -45.251.135 $ | -37,1 % | 1 | 121.817.933 $ | +47.153.010 $ | +63,2 % | 1 | 74.664.923 $ | +26.295.339 $ | +54,4 % | 1 |
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 99.003.125 $ | +13.906.902 $ | +16,3 % | 1 | ||||||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Schwach | 80.209.698 $ | +38.189.405 $ | +90,9 % | 1 | ||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 72.741.245 $ | +15.585.007 $ | +27,3 % | 1 | 75.973.259 $ | +1.521.692 $ | +2,0 % | 1 | ||||
| Nuvalent, Inc. | NUVL | → 0 | 73.185.562 $ | +10.265.914 $ | +16,3 % | 1 | |||||||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 70.260.412 $ | +42.468.636 $ | +152,8 % | 1 | ||||||||
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Stark | 68.839.338 $ | +19.784.883 $ | +40,3 % | 1 | ||||||||
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 67.926.914 $ | +3.319.736 $ | +5,1 % | 1 | ||||||||
| 1.184.138.486 $ | +353.349.787 $ | +35,7 % | 7 | 1.151.920.009 $ | +465.108.015 $ | +75,7 % | 9 | 798.479.540 $ | +254.993.478 $ | +60,6 % | 9 | ||||